Journals / Çocuk ve Gençlik Ruh Sağlığı Dergisi / 2019 / Cilt: 26 - Sayı: 3

Clonidine Treatment in a Case with Intellectual Disability Accompanied by Attention Deficit Hyperactivity Disorder and Conduct Disorder

Entelektüel Yetersizliğe Eşlik Eden Dikkat Eksikliği Hiperaktivite Bozukluğu ve Davranım Bozukluğu Olgusunda Klonidin Tedavisi

Pages
140–142
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this report, we present an adolescent boy with intellectual disability and comorbid attention deficit hyperactivity disorder, conduct disorder, who was unresponsive to methylphenidate and atomoxetine but significantly benefited from clonidine treatment in ADHD symptoms and associated behavioral problems.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In children and adolescents with intellectual disabilities, both physical and psychiatric comorbidity rates are higher than in developmentally normal children and attention deficit hyperactivity disorder and conduct disorder are among the most common psychiatric conditions.
📊
Key Findings & Data:Treatment of children with intellectual disability is similar to the treatment of attention deficit hyperactivity disorder (ADHD) with developmentally normal children, but in various cases, different treatment options such as alpha-2 agonists are needed.
💡
Conclusion & Impact:In this report, we present an adolescent boy with intellectual disability and comorbid attention deficit hyperactivity disorder, conduct disorder, who was unresponsive to methylphenidate and atomoxetine but significantly benefited from clonidine treatment in ADHD symptoms and associated behavioral problems.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In children and adolescents with intellectual disabilities, both physical and psychiatric comorbidity rates are higher than in developmentally normal children and attention deficit hyperactivity disorder and conduct disorder are among the most common psychiatric conditions. Treatment of children with intellectual disability is similar to the treatment of attention deficit hyperactivity disorder (ADHD) with developmentally normal children, but in various cases, different treatment options such as alpha-2 agonists are needed. In this report, we present an adolescent boy with intellectual disability and comorbid attention deficit hyperactivity disorder, conduct disorder, who was unresponsive to methylphenidate and atomoxetine but significantly benefited from clonidine treatment in ADHD symptoms and associated behavioral problems.

Özet

Entelektüel yetersizliği olan çocuk ve ergenlerde hem fiziksel hem de psikiyatrik ek tanı oranları yüksek olup dikkat eksikliği hiperaktivite bozukluğu, davranım bozukluğu en sık görülen psikiyatrik durumlar arasındadır. Entelektüel yetersizliği olan dikkat eksikliği hiperaktivite bozukluğu (DEHB) olan çocukların tedavisi de tipik gelişim gösteren çocuklarda kullanılan ilaçlar ile yapılmakla birlikte çeşitli durumlarda alfa-2 agonistler gibi farklı tedavi seçeneklerine ihtiyaç duyulmaktadır. Bu yazıda, hafif derecede entelektüel yetersizliği, dikkat eksikliği hiperaktivite bozukluğu, davranım bozukluğu olan, metilfenidat ve atomoksetin tedavisinden fayda sağlanamayan, ancak klonidin tedavisi sonrası DEHB semptomları ve eşlik eden davranışsal sorunlar açısından belirgin fayda gözlenen 15 yaşında bir erkek olgu sunulacaktır.

🔖

Cite This Article

BASKIN, E. S., BİLGİÇ, A. (2019). Clonidine Treatment in a Case with Intellectual Disability Accompanied by Attention Deficit Hyperactivity Disorder and Conduct Disorder. Çocuk ve Gençlik Ruh Sağlığı Dergisi, Cilt: 26 - Sayı: 3, 140–142. https://ajindex.com/articles/151094

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Durukan İ. Zeka Geriliği (Zihinsel Engellilik). Çocuk ve Ergen Ruh Sağlığı ve Hastalıkları. Akay AP, Ercan ES, Perçinel İ, Ardıç ÜA, Güney SA, Demirkaya SK, Güler AS, Yazıcı KU, eds. Ankara: Türkiye Çocuk ve Genç Psikiyatrisi Derneği Yayınları 2016;114-125
  2. Şengül ŞS. Zeka geriliği olan çocuklarda tamamlayıcı ve alternatif tedavi uygulamaları. Anadolu Psikiyatri Derg. 2009;10:24-5
  3. Volkmar FR, Dykens E. Mental Retardation. In: Levis M, eds. Köroğlu E, (çev). Child and adolescent psychiatry. Philadelphia: Lippincott Williams and Wilkins. 2003;603-611
  4. Biederman J, Spencer TJ, Wilens TE, Prince JB, Faraone SV. Commentary: Treatment of ADHD with stimulant medications: Response to Nissen perspective in The New England Journal of Medicine. J Am Acad Child Adolesc Pyschiatry. 2006;45:1147-1150
  5. Aman MG, Buican B, Arnold LE. Methylphenidate treatment in children with borderline IQ and mental retardation: Analysis of three aggregated studies. J Child Adolesc Psychopharmacol. 2003;13:29-40
  6. Simonoff E, Taylor E, Baird G, Bernard S, Chadwick O, Liang H, Whitwell S, Riemer K, Sharma K, Sharma SP, Wood N, Kelly J, Golaszewski A, Kennedy J, Rodney L, West N, Walwyn R, Jichi F. Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability. J Child Psychol Psychiatry. 2013;54:527-535
  7. Fernández-Jaén A, Fernández-Mayoralas DM, Pérez BC, Muñoz - Jareño N, Campos-Diáz M. Atomoxetine for attention deficit hyperactivity disorder in menta retardation. Pediatric Neurology. 2010;43:341-347
  8. Wilens TE, Kratochvil C, Newcorn JH, Gao H. Do children and adolescents with ADHD respond differently to atomoxetine?. Journal of theAmerican Academy of Child &Adolescent Psychiatry. 2006;45:149-157
  9. Karadağ M, Gökçen C. Mental Retardasyonu Olan Çocuk ve Ergenlerin Tedavisinde Kullanılan Farmakolojik Ajanlar. Çocuk ve Gençlik Ruh Sağlığı Dergisi. 2017;24:271-282
  10. Connor DF, Barkley RA, Davis HT. A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. Clin Pediatr. 2000;39:15-25
  11. Hazell PL & Stuart JE. A randomized controlled trial of clonidine added to psychostimulant medication for hyperactive and aggressive children. J Am Acad. 2000;42:886-894
  12. Connor DF, Findling RL, Kollins SH, Sallee F, López FA, Lyne A, Tremblay G. Effects of guanfacine extended rel